The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPIX.L Regulatory News (PPIX)

  • There is currently no data for PPIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ProPhotonix Offers New Higher Intensity UV Curing

3 Apr 2019 07:00

RNS Number : 8871U
ProPhotonix Limited
03 April 2019
 

 

 

April 3, 2019

ProPhotonix Limited

("ProPhotonix" or "the Company")

 

New Compact UV LED Curing System from ProPhotonix Offering 20% Higher Intensity

COBRA Cure FX1 Max delivers up to 6.4W/cm2 or 7.8J/cm2 from the same FX1 form factor maintaining excellent lifetime

 

ProPhotonix Limited (London Stock Exchange - AIM: PPIX & PPIR, OTC: STKR), a high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the United Kingdom, is pleased to announce the release of COBRA Cure FX1 Max, a compact, fan-cooled UV LED curing system designed to deliver maximum power density and dose for applications where space is restricted.

 

In developing the COBRA Cure FX1 Max, ProPhotonix has utilized its expertise in optical, mechanical and electronic engineering to design a UV LED Curing system that offers 20% increased output (up to 6.4W/cm2 intensity and 7.8J/cm2 maximum dose at 2mm working distance) without compromising on LED lifetime and reliability. The new UV LED curing lamp has been independently tested to verify its lifetime.

 

COBRA Cure FX1 Max is built with Chip-on-Board LED technology for maximum intensity and uniformity. It delivers a consistent, stable and reliable cure from a compact, easy-to-install, UV lamp. COBRA Cure FX1 Max is ideal for UV curing in printing and 3D Printing applications as well as curing of coatings and adhesives.

 

Ken Reynolds, Business and Technology Manager, ProPhotonix said: "The COBRA Cure FX1 Max significantly improves the dose levels available to those requiring a compact, fan-cooled UV LED curing system. ProPhotonix COBRA Cure FX1 Max delivers a powerful solution allowing customers to optimize space requirements and meet their reliability needs. ProPhotonix recognizes the importance of innovation, quality and reliability to our customers and provides patented, UL and CE certified COBRA Cure FX1 products from our ISO- certified facility."

 

For more information on COBRA Cure FX1 Max, visit https://www.prophotonix.com/led-and-laser-products/uv-led-curing-systems/cobra-cure-fx1-max/ or contact ProPhotonix on sales@prophotonix.com

 

 

Enquiries:

ProPhotonix Limited

sales@prophotonix.com

Ken Reynolds, Business and Technology Manager

Tel: +353 (0)21 500 1313

 

About ProPhotonix

 

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of LED illumination systems and laser diode modules for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio, Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's website at www.prophotonix.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAUGUWWCUPBGCP
Date   Source Headline
13th Aug 20127:00 amRNSHalf Yearly Report
25th May 20122:30 pmRNSGrant of Options (Replacement)
17th May 20127:00 amRNSAGM Statement
1st May 20124:21 pmRNSPosting of Annual Report and Accounts
5th Apr 20127:00 amRNSAppointment of Three New Distribution Partners
26th Mar 20127:00 amRNSGrant of Options
19th Mar 20127:00 amRNSAppointment of Joint Broker
1st Mar 20127:00 amRNSFinal Results
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
19th Jan 20127:00 amRNSTrading Update and New Product Launch
27th Oct 20117:00 amRNS3rd Quarter Results
28th Jul 20117:00 amRNSHalf Yearly Report
20th Jul 20117:00 amRNSNotice of Results
13th Jul 20117:00 amRNSIssue of Equity
26th May 20111:51 pmRNSDirector/PDMR Shareholding
24th May 20115:09 pmRNSDirector/PDMR Shareholding
10th May 20117:00 amRNSChange of Adviser
4th May 20117:00 amRNS1st Quarter Results
19th Apr 20115:28 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.